Clinical Trials Sponsored by Stallergenes Greer

Total 195 results

Stallergenes Greer

Active, not recruiting

Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma (YOBI)

Allergic Rhinoconjunctivitis | Birch Pollen Allergy

Germany
Stallergenes Greer

Completed

Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Children Suffering From Grass Pollen Rhinoconjunctivitis

Allergy

Germany
Stallergenes Greer

Completed

Phase III Study to Assess the Long Term Efficacy, Carry-over Effect and Safety of 300 IR Sublingual Immunotherapy Tablets

Allergy

France
Stallergenes Greer

Completed

A Phase III Study to Assess Efficacy and Safety of STALORAL® 300 IR Sublingual Immunotherapy (SLIT) in Asthmatic Patients Allergic to House-dust Mites

Allergy

China
Stallergenes Greer

Completed

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Asthma | House Dust Mite Allergy

France
Stallergenes Greer

Terminated

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis in Adolescents and Children

Allergic Rhinitis Due to Dust Mite
Stallergenes Greer

Terminated

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

Allergy

France
Stallergenes Greer

Completed

Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR

Rhinitis, Allergic, Perennial | House Dust Mite Allergy

France, United States
Stallergenes Greer

Completed

Safety and Efficacy on Phase III Study on 300 IR SLIT to Patients Suffering From Grass Pollen Rhinoconjunctivitis

Primary Disease

France, Italy, Spain
Stallergenes Greer

Completed

Safety and Efficacy of Sublingual Immunotherapy (SLIT) Tablets in Grass Pollen Rhinoconjunctivitis

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Stallergenes Greer

Completed

Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

Allergic Rhinitis
Stallergenes Greer

Completed

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

Allergic Rhinitis Due to Grass Pollens

United States
Stallergenes Greer

Completed

Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma

Asthma | House Dust Mite Allergy

France, Germany, Poland
Stallergenes Greer

Completed

Sensitivity and Specificity of 3 Solutions of Allergen Extract for Diagnosis by Skin Prick Testing

Allergy
Stallergenes Greer

Completed

Efficacy and Safety of 100IR, 300IR, 500IR Sublingual House Dust Mite (HDM) Tablets in Allergic Rhinitis Environment Exposure Chamber Model

House Dust Mites Allergic Rhinitis

Canada
Stallergenes Greer
Registrat-Mapi

Terminated

International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis (ALTO)

Allergic Rhinitis Due to Grass Pollens

France
Stallergenes Greer
Syneos Health

Completed

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents

House Dust Mite Allergic Rhinitis

Canada
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of rBet v1 SLIT Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
Stallergenes Greer
Quintiles, Inc.

Completed

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Rhinitis, Allergic, Seasonal | Birch Pollen-Related Rhinoconjunctivitis

Denmark
Stallergenes Greer
Quintiles, Inc.

Completed

Safety and Tolerability Study of Ragweed SLIT Tablets

Rhinitis, Allergic, Seasonal | Ragweed Pollen Allergy

Hungary
Stallergenes Greer
Monitoring Force Group

Completed

Treatment Modalities in Children and Adolescents Suffering From HDM-induced Allergic Rhinitis and/or Asthma (PROTECT)

Allergy
Stallergenes Greer
Venn Life Sciences

Completed

Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis

Allergy

Germany
Stallergenes Greer
Quintiles, Inc.; Aptuit

Completed

Study of rBet v1 Tablets

Rhinitis, Allergic, Seasonal | Birch Pollen-related Rhinoconjunctivitis

Denmark, Finland, France, Poland, Germany, Lithuania, Russian Federation, Sweden
Stallergenes Greer
Quintiles, Inc.; Cenduit LLC; Aptuit Inc.; PHT Corporation

Completed

Efficacy and Safety Study of a Sublingual Immunotherapy Solution to Treat Patients Suffering From Birch Pollen Allergic Rhinoconjunctivitis

Hypersensitivity | Allergic Rhinitis | Allergic Conjunctivitis | Seasonal Allergy

Czech Republic, Denmark, Estonia, Finland, France, Germany, Latvia, Lithuania, Poland, Slovakia, Sweden
University Hospital, Lille
Stallergenes Greer; Région Nord-Pas de Calais, France

Active, not recruiting

Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years) (VIRASTHMA2)

Asthma
Greer Laboratories

Completed

Efficacy and Safety Study Of Short Ragweed Pollen Sublingual-Oral Immunotherapy

Allergy

United States
Greer Laboratories

Completed

Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies

Allergic Rhinitis

United States
Pure Green

Recruiting

Cannabinoid Tablets for the Treatment of Pain From Osteoarthritis of the Knee

Osteoarthritis, Knee

United States
Pure Green

Unknown

Osteoarthritis of the Knee Pain Study Using a CBD and THC Sublingual Tablet

Pain | Osteoarthritis, Knee

United States
Green Beat

Completed

Strong Women Study

Inflammation | Oxidative Stress

Austria
Green Beat

Completed

Probiotic Sport Study

Inflammation | Endotoxemia | Oxidative Stress

Austria
Pure Green

Unknown

Using Cannabidiol to Treat Diabetic Peripheral Neuropathy of the Feet

Diabetic Peripheral Neuropathic Pain

United States
Pure Green

Completed

Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain

Musculoskeletal Pain

United States
Pure Green

Completed

The Use of a Water Soluble Under the Tongue (Sublingual) CBD Tablet for Treating Pain Associated With Diabetic Peripheral Neuropathy

Diabetic Neuropathies

United States
Pure Green

Unknown

Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea

Fatigue | Nausea | Dysmenorrhea | Headache, Migraine | Mood Disturbance

United States
Green Cross Wellbeing

Recruiting

GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health

Respiratory Symptoms

Korea, Republic of
Green Cross Wellbeing

Recruiting

Part A: In Patients With Chronic Liver Diseases, LAENNEC (Human Placenta Hydrolysate) is to Assess Safety and Tolerability After the Doses of Doses. Part B: Part A, it is to Determine the Optimal Dose by Evaluating Two Capacity and Placebo Groups.

Chronic Liver Disease

Korea, Republic of
Green Cross Wellbeing

Not yet recruiting

GCWB1176 Evaluates the Effectiveness and Safety of Immune Function

Immune Function

Korea, Republic of
Johns Hopkins University
Duke University; Greer Laboratories

Completed

The Safety and Efficacy of Sublingual/Oral Immunotherapy for the Treatment of Milk Protein Allergy

Milk Allergy

United States
West Penn Allegheny Health System
Greer Laboratories

Completed

Normal Values of Facial Thermography

Healthy | Allergy | Allergic Rhinoconjunctivitis

United States
Pure Green Pharmaceuticals Inc.

Not yet recruiting

Diabetic Neuropathic Pain Relief, 6 Weeks Dosage Sublingual Water-soluble CBD/PEA

Diabetic Peripheral Neuropathic Pain

United States
Bowling Green State University

Unknown

FReedom From Emotional Eating

Overweight and Obesity | Emotional Eating
AVIR Green Hills Biotechnology AG

Completed

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Influenza, Avian

Russian Federation
Green Valley Group of China

Unknown

Effects of Salvianolate Injection on Myocardial Microcirculation in Patients With Acute STEMI After Primary PCI (SISTEMI)

STEMI - ST Elevation Myocardial Infarction

China
Jennerex Biotherapeutics
Green Cross Corporation

Completed

A Study of Recombinant Vaccinia Virus to Evaluate the Safety and Efficacy of a Transdermal Injection Within the Tumor of Patients With Primary or Metastatic Hepatic Carcinoma

Neoplasms, Liver

Korea, Republic of
The Green Light Study Center

Recruiting

Green Light Effect on Sleep

Sleep

United States
CB2 Insights
Green Lotus Hemp

Withdrawn

Cannabidiol for Anxiety

Anxiety
AVIR Green Hills Biotechnology AG

Completed

Dose Finding Study of Single Dose GHB11L1 in Healthy Adults (GHB-CS07)

Influenza, Human

Austria
AVIR Green Hills Biotechnology AG

Completed

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

Seasonal Human Influenza

Austria

3

Subscribe